U.S. Healthcare IoT Security Market Size, Share & Forecast 2026–2032

ID: MR-11923 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Healthcare IoT Security
  • ✓Market Size 2024: USD 2.8 billion
  • ✓Market Size 2032: USD 6.9 billion
  • ✓CAGR: 12.0%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Nearshore Firmware Validation Gap: Tijuana assemblers ship much of the US-bound patient monitoring hardware, yet firmware signing and SBOM validation run through US labs. That split adds weeks to every cybersecurity patch cycle.
FINDING 02
Manufacturers Fund Security Upstream: Most analysts assume hospital IT budgets drive healthcare IoT security spending. Premarket obligations under Section 524B are shifting that spend upstream, as device makers such as GE HealthCare and Philips fund security engineering before hardware ships.
ANALYST RECOMMENDATION

Analyst Recommendation — Audit Legacy Devices Now: Device OEMs and health systems should commission SBOM-based vulnerability audits of all networked monitors and infusion pumps before Q4 2026. Early audits reduce FDA resubmission risk and lower cyber-insurance premiums across the installed base.

The U.S. Role in the Global Healthcare IoT Security Supply Chain

The United States anchors the demand side of the healthcare IoT security chain rather than its component base. Domestic OEMs such as GE HealthCare and Baxter ship networked monitors and pumps, but the semiconductors, radios and embedded modules inside them arrive largely from Taiwan, South Korea and China. Mexico supplies a large share of finished US-bound device assembly, making the country a security-sensitive importer at the end of a long chain.

Value capture sits with US firms at the software layer. Claroty, Armis, Forescout and Ordr build asset-visibility platforms headquartered in the US or with major US operations, selling into roughly 6,000 hospitals. Puerto Rico hosts FDA-registered device manufacturing that feeds national supply, so any cyber-driven shutdown there becomes a supply risk for both domestic and export markets.

Growth Drivers for U.S. Healthcare IoT Security

Connected device density is the first driver. Hospitals now link far more devices per bed than a decade ago, and CMS expanded remote patient monitoring reimbursement in 2024 and 2025. Each additional device enlarges the inventory that hardware and software vendors must protect, lifting demand for passive monitoring, network segmentation and firmware management.

Regulation is the second driver. Section 524B of the FD&C Act requires cyber device manufacturers to submit SBOMs and vulnerability management plans before premarket clearance, pulling security spend into product engineering. Ransomware losses after the 2024 Change Healthcare attack, which exposed data on about 190 million people, push boards to fund managed monitoring. Reshoring incentives in Puerto Rico add a third driver by bringing firmware validation onshore.

Supply Chain Risks and Trade Barriers

Semiconductor dependency is the primary risk. Microcontrollers and wireless chips inside monitors and infusion pumps come largely from Taiwan and China, and legacy components often lack secure boot or update support. Many installed devices run operating systems no longer patched by vendors, leaving hospitals unable to close vulnerabilities without replacing hardware.

Trade barriers add friction and cost. FCC Covered List restrictions bar certain Chinese-origin equipment, while Section 301 tariffs on Chinese medical inputs raise costs for module suppliers. USMCA compliance for Mexican assembly demands rules-of-origin documentation, and a peso swing can shift contract manufacturing economics on short notice.

Trade and Investment Opportunities in U.S. Healthcare IoT Security

Onshore SBOM and firmware validation labs represent a clear investment gap. Puerto Rico's manufacturing base and Act 60 incentives make it a logical site for FDA-aligned cybersecurity testing, serving Mexican-assembled devices that cross the border for final certification. Testing contractors that document component provenance can capture fees from both OEMs and importers.

Managed security services for rural hospitals and ambulatory surgery centers remain underserved. Vendors bundling asset discovery with around-the-clock monitoring can sell to facilities without dedicated security staff. Foreign security firms seeking US healthcare channels also present acquisition targets, as Claroty's 2022 purchase of Medigate showed.

Market at a Glance

MetricDetail
Market Size 2024USD 2.8 billion
Market Size 2032USD 6.9 billion
Growth Rate (CAGR)12.0%
Most Critical Decision FactorDevice-level SBOM and FDA premarket cybersecurity compliance
Largest RegionNortheast United States
Competitive StructureFragmented, with specialist platforms and diversified security majors

Leading Market Participants

  • Claroty
  • Armis
  • Forescout Technologies
  • Palo Alto Networks
  • Cisco Systems
  • Fortinet
  • Ordr
  • Asimily
  • Cylera
  • Nozomi Networks

Regulatory and Trade Policy Environment

Primary federal rules include FD&C Act Section 524B, FDA premarket cybersecurity guidance, and the HHS Healthcare and Public Health Cybersecurity Performance Goals. The HIPAA Security Rule governs patient data handling across connected devices. USMCA provides duty-free treatment for qualifying Mexican-origin devices, while most Chinese-origin medical goods face Section 301 duties.

Investment oversight runs through CFIUS, which reviews foreign acquisitions of security vendors handling hospital data. Executive Order 14028 mandates software bills of materials for federal supply chains, and the FCC Cyber Trust Mark sets a labeling baseline for connected consumer devices. A 2025 Section 232 investigation into medical devices could add tariffs on imported finished equipment.

Healthcare IoT Security Supply Chain Outlook to 2032

Asset visibility shifts from an add-on purchase to an embedded product feature. Device makers will ship hardware with built-in SBOMs and secure boot, shrinking the pool of unpatchable legacy assets over time. Puerto Rico and Mexican assembly sites will host more pre-shipment security testing, pulling validation work upstream into the supply chain.

AI-driven anomaly detection and the migration to post-quantum cryptography will alter comparative advantage. US vendors combining cloud analytics with FDA regulatory expertise retain leverage in this transition. Module suppliers unable to document component provenance will lose hospital contracts as procurement teams tighten sourcing requirements.

Frequently Asked Questions

Most networked monitors and pumps are assembled in Mexico from chips sourced in Taiwan and China. Security gaps introduced at any of these nodes reach US hospitals within one procurement cycle.
It requires manufacturers to submit SBOMs and vulnerability management plans before premarket clearance. Suppliers must document component origin, which shifts compliance costs upstream.
Section 301 duties apply to many Chinese-origin medical inputs, while USMCA provides preferential treatment for qualifying Mexican goods. A pending Section 232 review could extend tariffs to finished devices.
Puerto Rico hosts FDA-registered device manufacturing and offers Act 60 incentives for technology services. Its role in cybersecurity testing is growing as firms seek onshore validation capacity.
Legacy hardware with unsupported operating systems and non-updatable chips creates the largest exposure. Dependence on foreign semiconductors adds long-term sourcing risk for replacement parts.

Market Segmentation

By Security Type
  • Network Security
  • Endpoint Security
  • Application Security
  • Cloud Security
  • Identity and Access Management
By Deployment Model
  • On-Premises
  • Cloud-Based
  • Hybrid
  • Managed Services
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics and Physician Offices
  • Diagnostic Laboratories
  • Home Healthcare Providers

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Healthcare IoT Security - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Security Type Insights
4.1 Network Security
4.2 Endpoint Security
4.3 Application Security
4.4 Cloud Security
4.5 Others
Chapter 05 Deployment Model Insights
5.1 On-Premises
5.2 Cloud-Based
5.3 Hybrid
5.4 Managed Services
5.5 Others
Chapter 06 End User Insights
6.1 Hospitals
6.2 Ambulatory Surgery Centers
6.3 Clinics and Physician Offices
6.4 Diagnostic Laboratories
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 Claroty
7.2.2 Armis
7.2.3 Forescout Technologies
7.2.4 Palo Alto Networks
7.2.5 Cisco Systems
7.2.6 Fortinet
7.2.7 Ordr
7.2.8 Asimily
7.2.9 Cylera
7.2.10 Nozomi Networks
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.